PURPOSE To provide evidence-based recommendations for practicing physicians and
other health care providers on immunotherapy and biomarker testing for head and neck …

PURPOSE To provide evidence-based recommendations for practicing physicians and
other healthcare providers on the management of salivary gland malignancy. METHODS …

PURPOSE The aim of this joint guideline is to provide evidence-based recommendations to
practicing physicians and other healthcare providers on definitive-intent chemoradiotherapy …

Squamous cell carcinoma of the head and neck (SCCHN) arises from epithelial cells and
occurs in the oral cavity, pharynx and larynx. Nasopharyngeal carcinoma (NPC) is a disease …

CUP accounts for< 5% of cancers but, because of its high mortality rate, its relative
contribution to cancer deaths is higher. 1 The incidence of CUP has been declining …

Background Patients with metastases in the lymph nodes of the neck and no obvious
primary tumor, neck cancer with unknown primary (NCUP), represent a management …

Introduction Metastasis is an important cause of high mortality and lethality of oral cancer.
Fusobacterium nucleatum (Fn) can promote tumour metastasis. Outer membrane vesicles …

18F-FDG PET/CT plays an important role in locating the primary tumor for patients with head
and neck cancer of unknown primary (HNCUP). Nevertheless, in some cases it can be …

Head and neck squamous cell carcinoma (HNSCC) is a common and frequently lethal
cancer with few therapeutic options. In particular, there are few effective targeted therapies …

Importance There is growing interest in the use of circulating plasma tumor human
papillomavirus (HPV) DNA for diagnosis and surveillance of patients with HPV-associated …